首页> 外文期刊>Molecular oncology. >Enhanced anticancer activity of a combination of docetaxel and Aneustat (OMN54) in a patient-derived, advanced prostate cancer tissue xenograft model
【24h】

Enhanced anticancer activity of a combination of docetaxel and Aneustat (OMN54) in a patient-derived, advanced prostate cancer tissue xenograft model

机译:多西他赛和Aneustat(OMN54)组合在患者源性晚期前列腺癌组织异种移植模型中的增强的抗癌活性

获取原文
           

摘要

The current first-line treatment for advanced metastatic prostate cancer, i.e. docetaxel-based therapy, is only marginally effective. The aim of the present study was to determine whether such therapy can be improved by combining docetaxel with Aneustat (
机译:当前用于晚期转移性前列腺癌的一线治疗,即基于多西他赛的治疗仅勉强有效。本研究的目的是确定多西他赛与Aneustat联合使用是否可以改善此类治疗(

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号